Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Hypertension and diastolic heart failure.

Gradman AH, Wilson JT.

Curr Cardiol Rep. 2009 Nov;11(6):422-9. Review.

PMID:
19863866
3.

Medical management of mild-to-moderate heart failure before the advent of beta blockers.

Abraham WT, Wagoner LE.

Am J Med. 2001 May 7;110 Suppl 7A:47S-62S. Review.

PMID:
11334776
4.

Hypertension and cardiac failure in its various forms.

Gaddam KK, Verma A, Thompson M, Amin R, Ventura H.

Med Clin North Am. 2009 May;93(3):665-80. doi: 10.1016/j.mcna.2009.02.005. Review.

PMID:
19427498
5.

[Pharmacological basis of antihypertensive drug therapy].

Kolck UW, Zaugg CE, Erne P.

Praxis (Bern 1994). 2004 May 12;93(20):847-56. German.

PMID:
15195836
6.

Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H587-96. doi: 10.1152/ajpheart.00298.2012. Epub 2012 Jun 22.

7.

From hypertension to heart failure.

Papademetriou V.

J Clin Hypertens (Greenwich). 2004 Oct;6(10 Suppl 2):14-7. Review.

8.

[Therapy for hypertension associated with heart failure].

Miyamoto H, Imaizumi T.

Nihon Naika Gakkai Zasshi. 2003 Feb 10;92(2):258-63. Review. Japanese. No abstract available.

PMID:
12652730
9.
10.

From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.

Gradman AH, Alfayoumi F.

Prog Cardiovasc Dis. 2006 Mar-Apr;48(5):326-41. Review.

PMID:
16627048
11.

Medical repair of hypertensive left ventricular remodeling.

Motz WH, Scheler S, Strauer BE.

J Cardiovasc Pharmacol. 1992;20 Suppl 1:S32-6. Review.

PMID:
1380616
12.

Pathophysiology and clinical aspects of hypertensive hypertrophy.

Vogt M, Motz WH, Schwartzkopf B, Strauer BE.

Eur Heart J. 1993 Jul;14 Suppl D:2-7. Review.

PMID:
8103741
13.

Treatment of hypertension in heart failure with preserved ejection fraction: role of the kidney.

Shinde AA, Anderson AS.

Heart Fail Clin. 2008 Oct;4(4):479-503. doi: 10.1016/j.hfc.2008.04.001. Review.

PMID:
18760759
14.
15.

[Arterial hypertension and systolic left ventricular dysfunction: therapeutic approach].

Anguita Sánchez M.

Rev Esp Cardiol. 1999;52 Suppl 3:34-8. Spanish.

16.

Treatment of diastolic dysfunction in hypertension.

Ginelli P, Bella JN.

Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):613-8. doi: 10.1016/j.numecd.2012.04.016. Epub 2012 Jun 27. Review.

PMID:
22743209
17.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Cochrane Database Syst Rev. 2014 Feb 1;(2):CD008117. doi: 10.1002/14651858.CD008117.pub2. Review.

PMID:
24488616
18.

[Arterial hypertension and cardiac decompensation].

Degaute JP.

Rev Med Brux. 1996 Sep;17(4):272-4. French.

PMID:
8927860
19.

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.

Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.

Cochrane Database Syst Rev. 2015 Jan 11;1:CD008170. doi: 10.1002/14651858.CD008170.pub2. Review.

PMID:
25577154
20.

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Müller-Brunotte R, Kahan T, López B, Edner M, González A, Díez J, Malmqvist K.

J Hypertens. 2007 Sep;25(9):1958-66.

PMID:
17762662

Supplemental Content

Support Center